Key result
Ginseng and its bioactive constituents exhibit diverse cardioprotective mechanisms in coronary heart disease, including vasodilation, antioxidant, and anti-inflammatory effects.
Why the study?
Coronary heart disease is a leading cause of global mortality and morbidity, highlighting the need for effective therapeutic strategies.
Does ginseng provide cardioprotective effects in the prevention and management of coronary heart disease?
Systematic Review
Does ginseng provide cardioprotective effects in the prevention and management of coronary heart disease?
Ginseng shows potential as a complementary therapy for coronary heart disease through multiple cardioprotective mechanisms, though robust clinical evidence is still required.
Answers are grounded in this paper and cite their sources.
Supports adjunctive ginseng use in CHD; extends mechanistic data but leaves clinical adoption open pending larger trials.
Coronary heart disease (CHD) is a leading cause of mortality and morbidity globally, highlighting the need for effective therapeutic strategies. This systematic review evaluates the cardioprotective mechanisms of ginseng and its potential as a complementary or adjunctive therapy in the prevention and management of CHD. A systematic literature search was conducted in major databases (SCOPUS, PubMed, Google Scholar) following PRISMA guidelines to identify relevant preclinical and clinical studies investigating ginseng's effects on CHD and associated cardiovascular conditions. Studies reporting positive outcomes related to the cardioprotective properties of ginseng or its active compounds were included for analysis. Ginseng and its bioactive constituents, especially ginsenosides, exhibit diverse cardioprotective mechanisms in CHD, including vasodilation, hypotensive, antioxidant, anti-hyperlipidemic effects, anti- atherosclerotic, antithrombotic, anti-inflammatory and various other molecular mechanism proven by preclinical and clinical studies that demonstrates ginseng can mitigates myocardial ischemia, improves cardiac contractility, and regulates blood pressure, lipid profiles, thrombus formation and glycemic control. Ginseng represents a promising natural therapeutic for CHD management due to its well-established safety profile and diverse cardioprotective properties targeting multiple pathways involved in disease pathophysiology. Although, more robust clinical evidence is needed. Integrating Ginseng into conventional treatment regimens, guided by scientific research, could enhance CHD management and improve patient outcomes.
No takes yet. Share an insight, caveat, or question.
Parmar et al. (2024) conducted a systematic review in Coronary heart disease (CHD). Ginseng was evaluated on Cardioprotective mechanisms and effects on CHD. Ginseng and its bioactive constituents exhibit diverse cardioprotective mechanisms in coronary heart disease, including vasodilation, antioxidant, and anti-inflammatory effects.
Synapse has enriched 10 related papers. Consider them for comparative context: